The encouraging pharmacological data in animals obtained in different connective tissues have lead the company to device a new project aimed at assessing HMGB1 efficacy in Bone Matrix.       

Bio3 Research has recently been granted from USPTO the US patent # 10/471,641 which claims the use of HMGB1 inhibitors and antagonists for the treatment of Cardiovascular Disorders…

You may also notice that we have a new website. This site was built by a company based in the UK called Sinful Design. They can be found at;

www.sinfuldesign.com